Our data are in line with a previous study that showed PD-L1 induction mediated by PARPi in breast cancer cell lines and in mice models and rendered PARPi-treated breast cancer cells resistant to T-cell killing [54]. The gene discussed is CD274; the disease is breast carcinoma.